Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.24 +0.38 (+2.10%)
At close: Sep 29, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Common Equity (2015 - 2026)

Updated

Syndax Pharmaceuticals' Common Equity was $15.1 million in Q2 2026, down 90.4% from $157.42 million a year earlier and down 63.7% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Common Equity (2015 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Syndax Pharmaceuticals came in at $64.63 million, down 77.6% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of -23.8% (FY2020 to FY2025).
  • In earlier years, Common Equity was $288.12 million in FY2024 (-48.0%), $554.2 million in FY2023 (+18.6%), $467.45 million in FY2022 (+14.5%) and $408.37 million in FY2021 (+61.9%).
  • The Q2 2026 figure marks the lowest quarterly Common Equity since Q4 2015.
  • Compared with a year earlier, Common Equity has declined for seven straight quarters, with an average decline of 60.4% over the last eight quarters.
  • The best year-over-year quarter for Common Equity over five years was Q3 2022 (growth of 69.9%); the worst was Q2 2026 (a decline of 90.4%).
  • Per Business Quant data, SNDX's Common Equity in the three quarters before Q2 2026 was $41.62 million (Q1 2026), $64.63 million (Q4 2025) and $115.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Syndax Pharmaceuticals 1.59 Bn -137.74 Mn 69.58 Mn 15.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.10 Mn
Mar 31, 2026 41.62 Mn
Dec 31, 2025 64.63 Mn
Sep 30, 2025 115.43 Mn
Jun 30, 2025 157.42 Mn
Mar 31, 2025 215.06 Mn
Dec 31, 2024 288.12 Mn
Sep 30, 2024 366.43 Mn
Jun 30, 2024 434.34 Mn
Mar 31, 2024 491.89 Mn
Dec 31, 2023 554.20 Mn
Sep 30, 2023 359.19 Mn
Jun 30, 2023 400.04 Mn
Mar 31, 2023 435.51 Mn
Dec 31, 2022 467.45 Mn
Sep 30, 2022 338.10 Mn
Jun 30, 2022 361.94 Mn
Mar 31, 2022 374.55 Mn
Dec 31, 2021 408.37 Mn
Sep 30, 2021 199.00 Mn
API Access

Syndax Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=SNDX&period=max&api_key=YOUR_API_KEY